Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,023 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Japanese Dermatological Association guidelines: Outlines of Japanese clinical guidelines for basal cell carcinoma 2021.
Hoashi T, Ishikawa M, Uehara J, Oashi K, Maeda S, Kato J, Saruta H, Shichinohe R, Ohashi R, Nakamura Y, Koga H, Sugaya M; Basal Cell Carcinoma Guidelines Committee of the Japanese Skin Cancer Society. Hoashi T, et al. Among authors: koga h. J Dermatol. 2024 Apr;51(4):e90-e105. doi: 10.1111/1346-8138.16944. Epub 2024 Jan 24. J Dermatol. 2024. PMID: 38264942
Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.
Sugaya M, Hamada T, Kawai K, Yonekura K, Ohtsuka M, Shimauchi T, Tokura Y, Nozaki K, Izutsu K, Suzuki R, Setoyama M, Nagatani T, Koga H, Tani M, Iwatsuki K. Sugaya M, et al. Among authors: koga h. J Dermatol. 2013 Jan;40(1):2-14. doi: 10.1111/j.1346-8138.2012.01639.x. Epub 2012 Aug 20. J Dermatol. 2013. PMID: 22900999
Dermoscopic evaluation of melanonychia.
Koga H. Koga H. J Dermatol. 2017 May;44(5):515-517. doi: 10.1111/1346-8138.13863. J Dermatol. 2017. PMID: 28447352 Review.
Japanese real-world study of sequential nivolumab and ipilimumab treament in melanoma.
Tsutsumida A, Fukushima S, Yokota K, Yoshikawa S, Yamasaki O, Tanemura A, Okuyama R, Uhara H, Muto Y, Miyashita A, Akiyama M, Kaji T, Koga H, Kato J, Katayama T, Itakura E, Yamazaki N, Kiyohara Y. Tsutsumida A, et al. Among authors: koga h. J Dermatol. 2019 Nov;46(11):947-955. doi: 10.1111/1346-8138.15073. Epub 2019 Sep 17. J Dermatol. 2019. PMID: 31531895
Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy-naive advanced melanoma.
Namikawa K, Kiyohara Y, Takenouchi T, Uhara H, Uchi H, Yoshikawa S, Takatsuka S, Koga H, Wada N, Minami H, Hatsumichi M, Namba Y, Yamazaki N. Namikawa K, et al. Among authors: koga h. J Dermatol. 2020 Nov;47(11):1257-1266. doi: 10.1111/1346-8138.15514. Epub 2020 Aug 18. J Dermatol. 2020. PMID: 32812243 Free PMC article. Clinical Trial.
2,023 results